Progress in the application of epimedium and its major bioactive components in the treatment of orthopedic diseases
Epimedium brevicornu (Yin Yang Huo), a widely used traditional Chinese medicinal ingredient, has garnered significant attention for its role in treating orthopedic diseases such as osteoporosis. Our work through network pharmacology and bioinformatics analysis, we identified that out of 27 major act...
Saved in:
| Main Authors: | Dan Tong, Long Chen, Zeyi Jiang, Xuxia Ye, Mengjie Ma, Angzhi Ye, Jian Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1628602/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anthracnose of Korean Epimedium Caused by Colletotrichum gloeosporioides
by: Wan-Gyu Kim, et al.
Published: (2024-12-01) -
Research Progress on the osteogenic differentiation of ADSCs induced by epimedium in the prevention and treatment of osteoporosis
by: Hai-Quan LIU, et al.
Published: (2023-10-01) -
Pharmacological actions of the bioactive compounds of Epimedium on the male reproductive system: current status and future perspective
by: Song-Po Liu, et al.
Published: (2025-01-01) -
Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway
by: Shan Shan Lei, et al.
Published: (2025-03-01) -
Epimedium Brevicornu and Curculigo orchioides inhibit osteoclast autophagy by degrading the level of miRNA-199 to regulate the mTOR signaling pathway
by: Mengyao Shi, et al.
Published: (2025-07-01)